Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging

Nanoprobes that offer both fluorescence imaging (FI) and magnetic resonance imaging (MRI) can provide supplementary information and hold synergistic advantages. However, synthesis of such dual-modality imaging probes that simultaneously exhibit tunability of functional groups, high stability, great...

Full description

Bibliographic Details
Main Authors: Xueyang Xiao, Hao Cai, Qiaorong Huang, Bing Wang, Xiaoming Wang, Qiang Luo, Yinggang Li, Hu Zhang, Qiyong Gong, Xuelei Ma, Zhongwei Gu, Kui Luo
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-01-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X22002031
_version_ 1798000720703651840
author Xueyang Xiao
Hao Cai
Qiaorong Huang
Bing Wang
Xiaoming Wang
Qiang Luo
Yinggang Li
Hu Zhang
Qiyong Gong
Xuelei Ma
Zhongwei Gu
Kui Luo
author_facet Xueyang Xiao
Hao Cai
Qiaorong Huang
Bing Wang
Xiaoming Wang
Qiang Luo
Yinggang Li
Hu Zhang
Qiyong Gong
Xuelei Ma
Zhongwei Gu
Kui Luo
author_sort Xueyang Xiao
collection DOAJ
description Nanoprobes that offer both fluorescence imaging (FI) and magnetic resonance imaging (MRI) can provide supplementary information and hold synergistic advantages. However, synthesis of such dual-modality imaging probes that simultaneously exhibit tunability of functional groups, high stability, great biocompatibility and desired dual-modality imaging results remains challenging. In this study, we used an amphiphilic block polymer from (ethylene glycol) methyl ether methacrylate (OEGMA) and N-(2-hydroxypropyl) methacrylamide (HPMA) derivatives as a carrier to conjugate a MR contrast agent, Gd-DOTA, and a two-photon fluorophore with an aggregation-induced emission (AIE) effect, TPBP, to construct a MR/two-photon fluorescence dual-modality contrast agent, Gd-DOTA-TPBP. Incorporation of gadolinium in the hydrophilic chain segment of the OEGMA-based carrier resulted in a high r1 value for Gd-DOTA-TPBP, revealing a great MR imaging resolution. The contrast agent specifically accumulated in the tumor region, allowing a long enhancement duration for vascular and tumor contrast-enhanced MR imaging. Meanwhile, coupling TPBP with AIE properties to the hydrophobic chain segment of the carrier not only improved its water solubility and reduced its cytotoxicity, but also significantly enhanced its imaging performance in an aqueous phase. Gd-DOTA-TPBP was also demonstrated to act as an excellent fluorescence probe for two-photon-excited bioimaging with higher resolution and greater sensitivity than MRI. Since high-resolution, complementary MRI/FI dual-modal images were acquired at both cellular and tissue levels in tumor-bearing mice after application of Gd-DOTA-TPBP, it has great potential in the early phase of disease diagnosis.
first_indexed 2024-04-11T11:24:52Z
format Article
id doaj.art-88c9c0d142614f0fabe97e3092e22091
institution Directory Open Access Journal
issn 2452-199X
language English
last_indexed 2024-04-11T11:24:52Z
publishDate 2023-01-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Bioactive Materials
spelling doaj.art-88c9c0d142614f0fabe97e3092e220912022-12-22T04:26:17ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2023-01-0119538549Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imagingXueyang Xiao0Hao Cai1Qiaorong Huang2Bing Wang3Xiaoming Wang4Qiang Luo5Yinggang Li6Hu Zhang7Qiyong Gong8Xuelei Ma9Zhongwei Gu10Kui Luo11Department of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaAmgen Bioprocessing Centre, Keck Graduate Institute, CA, 91711, USADepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Functional and Molecular Imaging Key Laboratory of Sichuan Province, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Corresponding author.Department of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Functional and Molecular Imaging Key Laboratory of Sichuan Province, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China; Corresponding author. Department of Radiology, Department of Biotherapy, Huaxi MR Research Center (HMRRC), Laboratory of Stem Cell Biology, Cancer Center, Department of Ultrasound, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.Nanoprobes that offer both fluorescence imaging (FI) and magnetic resonance imaging (MRI) can provide supplementary information and hold synergistic advantages. However, synthesis of such dual-modality imaging probes that simultaneously exhibit tunability of functional groups, high stability, great biocompatibility and desired dual-modality imaging results remains challenging. In this study, we used an amphiphilic block polymer from (ethylene glycol) methyl ether methacrylate (OEGMA) and N-(2-hydroxypropyl) methacrylamide (HPMA) derivatives as a carrier to conjugate a MR contrast agent, Gd-DOTA, and a two-photon fluorophore with an aggregation-induced emission (AIE) effect, TPBP, to construct a MR/two-photon fluorescence dual-modality contrast agent, Gd-DOTA-TPBP. Incorporation of gadolinium in the hydrophilic chain segment of the OEGMA-based carrier resulted in a high r1 value for Gd-DOTA-TPBP, revealing a great MR imaging resolution. The contrast agent specifically accumulated in the tumor region, allowing a long enhancement duration for vascular and tumor contrast-enhanced MR imaging. Meanwhile, coupling TPBP with AIE properties to the hydrophobic chain segment of the carrier not only improved its water solubility and reduced its cytotoxicity, but also significantly enhanced its imaging performance in an aqueous phase. Gd-DOTA-TPBP was also demonstrated to act as an excellent fluorescence probe for two-photon-excited bioimaging with higher resolution and greater sensitivity than MRI. Since high-resolution, complementary MRI/FI dual-modal images were acquired at both cellular and tissue levels in tumor-bearing mice after application of Gd-DOTA-TPBP, it has great potential in the early phase of disease diagnosis.http://www.sciencedirect.com/science/article/pii/S2452199X22002031RAFT polymerizationAmphiphilic block polymersMagnetic resonance/fluorescence dual-modal imagingTumor/vascular imagingTwo-photon AIE fluorescent contrast agent
spellingShingle Xueyang Xiao
Hao Cai
Qiaorong Huang
Bing Wang
Xiaoming Wang
Qiang Luo
Yinggang Li
Hu Zhang
Qiyong Gong
Xuelei Ma
Zhongwei Gu
Kui Luo
Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
Bioactive Materials
RAFT polymerization
Amphiphilic block polymers
Magnetic resonance/fluorescence dual-modal imaging
Tumor/vascular imaging
Two-photon AIE fluorescent contrast agent
title Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
title_full Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
title_fullStr Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
title_full_unstemmed Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
title_short Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging
title_sort polymeric dual modal imaging nanoprobe with two photon aggregation induced emission for fluorescence imaging and gadolinium chelation for magnetic resonance imaging
topic RAFT polymerization
Amphiphilic block polymers
Magnetic resonance/fluorescence dual-modal imaging
Tumor/vascular imaging
Two-photon AIE fluorescent contrast agent
url http://www.sciencedirect.com/science/article/pii/S2452199X22002031
work_keys_str_mv AT xueyangxiao polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT haocai polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT qiaoronghuang polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT bingwang polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT xiaomingwang polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT qiangluo polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT yinggangli polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT huzhang polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT qiyonggong polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT xueleima polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT zhongweigu polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging
AT kuiluo polymericdualmodalimagingnanoprobewithtwophotonaggregationinducedemissionforfluorescenceimagingandgadoliniumchelationformagneticresonanceimaging